Review of clinical experience with ion beam radiotherapy

British Journal of Radiology

Volumn 84, Issue SPEC. ISSUE 1, 2011, Pages

  Jensen, Alexandra D ^a   Munter M W ^a   Debus, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOID CYSTIC CARCINOMA; CANCER RADIOTHERAPY; CHONDROSARCOMA; CHORDOMA; ESOPHAGUS CARCINOMA; EVIDENCE BASED PRACTICE CENTER; FRACTIONATED STEREOTACTIC RADIOTHERAPY; HELIUM ION RADIATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; PANCREAS CARCINOMA; PARTICLE RADIATION; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RADIATION HAZARD; REVIEW; SALIVARY GLAND TUMOR; SKULL TUMOR; UTERINE CERVIX CARCINOMA; UVEA MELANOMA;

CARCINOMA, ADENOID CYSTIC; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NON-SMALL-CELL LUNG; CHONDROSARCOMA; CHORDOMA; EQUIPMENT DESIGN; ESOPHAGEAL NEOPLASMS; FEMALE; HEAVY IONS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MELANOMA; NEOPLASMS; PANCREATIC NEOPLASMS; PARTICLE ACCELERATORS; PROSTATIC NEOPLASMS; RADIOTHERAPY, HIGH-ENERGY; SALIVARY GLAND NEOPLASMS; SKULL BASE NEOPLASMS; UTERINE CERVICAL NEOPLASMS; UVEAL NEOPLASMS;

EID: 84857828153     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/71511359     Document Type: Review

References (85)

1. Castro JR, Char DH, Petti PL, Daftari IK, Quivey JM, Singh RP, et al. 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 1997;39:989-96. (Pubitemid 27506149)
2. Castro JR, Linstadt DE, Bahary JP, Petti PL, Daftari I, Collier JM, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994;29:647-55. (Pubitemid 24241302)
3. Linstadt D, Quivey JM, Castro JR, Andejeski Y, Phillips TL, Hannigan J, et al. Comparison of helium-ion radiation therapy and split-course megavoltage irradiation for unresectable adenocarcinoma of the pancreas. Final report of a Northern California Oncology Group randomized prospective clinical trial. Radiology 1988;168:261-4.
4. Saunders W, Castro JR, Chen GT, Collier JM, Zink SR, Pitluck S, et al. Helium-ion radiation therapy at the Lawrence Berkeley Laboratory: recent results of a Northern California Oncology Group Clinical Trial. Radiat Res Suppl 1985;8:S227-34. (Pubitemid 16149322)
5. Schulz-Ertner D, Nikoghosyan A, Hof H, Didinger B, Combs SE, Jäkel O, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys 2007;67:171-7. (Pubitemid 44959492)
6. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jäkel O, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007;68:449-57. (Pubitemid 46694169)
7. Schulz-Ertner D, Nikoghosyan A, Didinger B, Münter M, Jäkel O, Karger CP, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005;104:338-44. (Pubitemid 40993261)
8. Nutting C, A'Hern R, Rogers MS, Sydenham MA, Adab F, Harrington K, et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) vs conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). PORC ASCO 2009, abstract # LBA6006.
9. Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, et al. Imatinib mesylate in chordoma. Cancer 2004;101:2086-97. (Pubitemid 39425386)
10. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993;100:1547-54. (Pubitemid 23292865)
11. Castro JR, Char DH, Petti PL, Daftari IK, Quivey JM, Singh RP, et al. 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 1997;39:989-96. (Pubitemid 27506149)
12. Courdi A, Caujolle JP, Grange JD, Diallo-Rosier L, Sahel J, Bacin F, et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 1999;45:5-11. (Pubitemid 29380068)
13. Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol 2000;118:773-8. (Pubitemid 30395173)
14. Fuss M, Loredo LN, Blacharski PA, Grove RI, Slater JD. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 2001;49:1053-9. (Pubitemid 32184612)
15. Desjardins L, Lumbroso L, Levy C, Mazal A, Delacroix S, Rosenwald JC, et al. Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates. J Fr Ophtalmol 2003;26:269-76. (Pubitemid 36722925)
16. Höcht S, Bechrakis NE, Nausner M, Kreusel KM, Kluge H, Heese J, et al. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol 2004;180:419-24. (Pubitemid 39207380)
17. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 2005;63:109-15. (Pubitemid 41583548)
18. Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys 2006;65:780-7. (Pubitemid 43795817)
19. Tsuji H, Ishikawa H, Yanagi T, Hirasawa N, Kamada T, Mizoe JE, et al. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 2007;67:857-62. (Pubitemid 46215870)
20. Egger E, Zografos L, Schalenbourg A, Beati D, Böhringer T, Chamot L, et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003;55:867-80. (Pubitemid 36286989)
21. Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 2000;47:591-6. (Pubitemid 30317475)
22. Romero J, Cardenes H, la Torre A, Valcarcel F, Magallon R, Regueiro C, et al. Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 1993;29:27-32. (Pubitemid 23336815)
23. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175:57-63. (Pubitemid 29533454)
24. Noel G, Habrand JL, Mammar H, Pontvert D, Haie-Meder C, Hasboun D, et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D'Orsay experience. Int J Radiat Oncol Biol Phys 2001;51:392-8. (Pubitemid 32884285)
25. Weber DC, Ritz HP, Pedroni ES, Bolsi A, Timmermann B, Verwey J, et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys 2005;63:401-9. (Pubitemid 41317156)
26. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999;45:351-8. (Pubitemid 29408548)
27. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. HeadNeck Surg 1986;8:177-84.
28. Chen AM, Granchi PJ, Garcia J, Bucci MK, Fu KK, Eisele DW. Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 2007;67:982-7.
29. Gurney TA, Eisele DW, Weinberg V, Shin E, Lee N. Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope 2005;115:1278-82. (Pubitemid 40962370)
30. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 2004;26:154-62. (Pubitemid 38160449)
31. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 2006;66:152-9. (Pubitemid 44175654)
32. Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, Peters LJ. Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 1994;73:2563-9. (Pubitemid 24155534)
33. Terhaard CHJ, Lubsen H, Van der Tweel I, Hilgers FJM, Eijkenboom WMH, Marres HAM, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 2004;26:681-92; discussion 692-3.
34. Bittner N, Koh WJ, Laramore GE, Patel S, Mulligan MS, Douglas JG. Treatment of locally advanced adenoid cystic carcinoma of the trachea with neutron radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:410-14.
35. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003;129:944-8. (Pubitemid 37087654)
36. Mizoe JE, Tsujii H, Kamada T, Matuoka Y, Tsuji H, Osaka Y, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:358-64. (Pubitemid 39233452)
37. Münter MW, Schulz-Ertner D, Hof H, Nikoghosyan A, Jensen A, Nill A, et al. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment. Radiat Oncol 2006;1:17.
38. Huber PE, Debus J, Latz D, Zierhut D, Bischof M, Wannenmacher M, et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 2001;59:161-7. (Pubitemid 32452309)
39. Pommier P, Liebsch NJ, Deschler DG, Lin DT, McIntyre JF, Barker FG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:1242-9. (Pubitemid 44800140)
40. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-81. (Pubitemid 17072411)
41. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999;116:1313-19. (Pubitemid 29535986)
42. Bush DA, Slater JD, Shin BB, Cheek GC, Miller DW, Slater JM. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004;126:1198-203. (Pubitemid 39391251)
43. Nihei K, Ogino T, Ishikura S, Nishimura H. High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:107-11.
44. Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe JE, et al. Carbon ion radiotherapy for stage I nonsmall cell lung cancer. Radiother Oncol 2003;66:127-40. (Pubitemid 36315822)
45. Koto M, Miyamoto T, Yamamoto N, Nishimura H, Yamada S, Tsujii H, et al. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 2004;71:147-56. (Pubitemid 38521182)
46. Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, et al. Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 2007;67:750-8. (Pubitemid 46215886)
47. Nishimura H, Miyamoto T, Yamamoto N, Koto M, Sugimura K, Tsujii H. Radiographic pulmonary and pleural changes after carbon ion irradiation. Int J Radiat Oncol Biol Phys 2003;55:861-6. (Pubitemid 36286988)
48. Kadono K, Homma T, Kamahra K, Nakayama M, Satoh H, Sekizawa K, et al. Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients. Chest 2002;122:1925-32. (Pubitemid 36051126)
49. Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, et al. Carbon ion radiotherapy for stage I nonsmall cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2007;2:916-26. (Pubitemid 47511595)
50. Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys 2007;68:786-93. (Pubitemid 46818733)
51. Shioyama Y, Tokuuye K, Okumura T, Kagei K, Sugahara S, Ohara K, et al. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003;56:7-13. (Pubitemid 36403671)
52. Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 2004;127:S189-93. (Pubitemid 39423387)
53. Sugahara S, Tokuuye K, Okumura T, Nakahara A, Saida Y, Kagei K, et al. Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 2005;61:76-84. (Pubitemid 40039108)
54. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74. (Pubitemid 34177421)
55. Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005;23:1839-46. (Pubitemid 46211361)
56. Kato H, Tsujii H, Miyamoto T, Mizoe JE, Kamada T, Tsuji H, et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004;59:1468-76. (Pubitemid 38954070)
57. Mizumoto M, Tokuuye K, Sugahara S, Hata M, Fukumitsu N, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma with inferior vena cava tumor thrombus: report of three cases. Jpn J Clin Oncol 2007;37:459-62. (Pubitemid 47249484)
58. Hata M, Tokuuye K, Sugahara S, Tohno E, Fukumitsu N, Hashimoto T, et al. Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites. Technical considerations and results. Strahlenther Onkol 2007;183:411-16. (Pubitemid 47230515)
59. Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chugannji Y, Kagei K, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005;11:3799-805. (Pubitemid 40685599)
60. Ohara K, Okumura T, Tsuji H, Chiba T, Min M, Tatsuzaki H, et al. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy. Int J Radiat Oncol Biol Phys 1997;38:367-72. (Pubitemid 27318654)
61. Hashimoto T, Tokuuye K, Fukumitsu N, Igaki H, Hata M, Kagei K, et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;65:196-202.
62. Robertson JM, Lawrence TS, Dworzanin LM, Andrews JC, Walker S, Kessler ML, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993;11:1286-93. (Pubitemid 23199131)
63. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirtyone patients. Acta Oncol 1995;34:861-70.
64. Yamada S, Kato H, Yamaguchi K, Kitabayashi H, Tsujii H, Saisyo H, et al. Carbon ion therapy for patients with localized, resectable adenocarcinoma of the pancreas. Proc ASCO GI 2005; Abstract #130.
65. Yamada S, Hara R. Carbon ion radiotherapy for pancreas cancer. Proceedings of the NIRS-MD Anderson symposium on clinical issues for particle therapy. NIRS M.D. Anderson Symposium, 3/2008.
66. Linstadt D, Quivey JM, Castro JR, Andejeski Y, Phillips TL, Hannigan J, et al. Comparison of helium-ion radiation therapy and split-course megavoltage irradiation for unresectable adenocarcinoma of the pancreas. Final report of a Northern California Oncology Group randomized prospective clinical trial. Radiology 1988;168:261-4.
67. Kato S, Ohno T, Tsujii H, Nakano T, Mizoe JE, Kamada T, et al. Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2006;65:388-97.
68. Matsushita K, Ochiai T, Shimada H, Kato S, Ohno T, Nikaido T, et al. The effects of carbon ion irradiation revealed by excised perforated intestines as a late morbidity for uterine cancer treatment. Surg Today 2006;36:692-700. (Pubitemid 44127337)
69. Kagei K, Tokuuye K, Okumura T, Ohara K, Shioyama Y, Sugahara S, et al. Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2003;55:1265-71. (Pubitemid 36338292)
70. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-87. (Pubitemid 36677372)
71. Park L, DeLaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, et al. Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 2006;65:1514-21. (Pubitemid 44425209)
72. Rutz HP, Weber DC, Sugahara S, Timmermann B, Lomax AJ, Bolsi A, et al. Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys 2007;67:512-20. (Pubitemid 46108303)
73. Imai R, Kamada T, Tsuji H, Yanagi T, Baba M, Miyyamoto T, et al. Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 2004;10:5741-6. (Pubitemid 39180950)
74. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, et al. Comparison of conventional-dose vs highdose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-9. (Pubitemid 41352111)
75. Zietman AL. Correction: inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate. JAMA 2008;299:898-9. (Pubitemid 351397078)
76. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3-12.
77. Yonemoto LT, Slater JD, Rossi CJ Jr, Antoine JE, Loredo L, Archambeau JO, et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. Int J Radiat Oncol Biol Phys 1997;37:21-9. (Pubitemid 27090131)
78. Rossi CJ Jr, Slater JD, Yonemoto LT, Jabola BR, Bush DA, Levy RP, et al. Influence of patient age on biochemical freedom from disease in patients undergoing conformal proton radiotherapy of organ-confined prostate cancer. Urology 2004;64:729-32. (Pubitemid 39446052)
79. Slater JD, Rossi CJ Jr, Yonemoto LT, Bush DA, Jabola BR, Levy RP, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004;59:348-52. (Pubitemid 38622585)
80. Mayahara H, Murakami M, Kagawa K, Kawaguchi A, Oda Y, Miyawaki D, et al. Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int J Radiat Oncol Biol Phys 2007;69:434-43. (Pubitemid 47380084)
81. Akakura K, Tsujii H, Morita S, Tsuji H, Yagashita T, Isaka S, et al. Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate 2004;58:252-8. (Pubitemid 38168922)
82. Ishikawa H, Tsuji H, Kamada T, Hirasawa N, Yanagi T, Mizoe JE, et al. Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:78-84.
83. Tsuji H, Yanagi T, Ishikawa H, Kamada T, Mizoe JE, Kanai T, et al. Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys 2005;63:1153-60. (Pubitemid 41505295)
84. Nihei K, Ogino T, Ishikura S, Kawashima M, Nishimura H, Arahira S, et al. Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan. Jpn J Clin Oncol 2005;35:745-52. (Pubitemid 43091660)
85. Shimazaki J, Akakura K, Suzuki H, Ichikawa T, Tsuji H, Ishikawa H, et al. Monotherapy with carbon ion radiation localized prostate cancer. Jpn J Clin Oncol 2006;36:290-4.